Dian Diagnostics Group Co.,Ltd. (SHE:300244)
China · Delayed Price · Currency is CNY 16.94
+0.38 (2.29%)
Sep 5, 2025, 3:04 PM CST
Dian Diagnostics Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 10,914 | 12,196 | 13,407 | 20,281 | 13,079 | 10,648 | Upgrade |
Other Revenue | 0.26 | 0.37 | 1.36 | 1.71 | 3.6 | 1.66 | Upgrade |
| 10,915 | 12,196 | 13,408 | 20,282 | 13,083 | 10,649 | Upgrade | |
Revenue Growth (YoY) | -14.63% | -9.04% | -33.89% | 55.03% | 22.85% | 25.98% | Upgrade |
Cost of Revenue | 7,891 | 8,811 | 9,256 | 12,809 | 8,100 | 6,596 | Upgrade |
Gross Profit | 3,023 | 3,385 | 4,152 | 7,473 | 4,983 | 4,053 | Upgrade |
Selling, General & Admin | 1,957 | 2,049 | 2,300 | 2,834 | 2,296 | 1,715 | Upgrade |
Research & Development | 272.24 | 305.88 | 432.64 | 638.47 | 424.75 | 319.1 | Upgrade |
Other Operating Expenses | 32.44 | 39.36 | 30.44 | 56.17 | 44.65 | 36.85 | Upgrade |
Operating Expenses | 2,685 | 2,839 | 3,139 | 3,817 | 2,856 | 2,151 | Upgrade |
Operating Income | 338.06 | 546.34 | 1,013 | 3,657 | 2,127 | 1,902 | Upgrade |
Interest Expense | -172.66 | -203.03 | -250.6 | -274.73 | -230.2 | -206.82 | Upgrade |
Interest & Investment Income | 67.26 | 64.38 | 41.76 | 69.62 | 77.47 | 92.6 | Upgrade |
Currency Exchange Gain (Loss) | -1.06 | -2.02 | 0.84 | -25.12 | -2.33 | 2.62 | Upgrade |
Other Non Operating Income (Expenses) | -15.74 | -35.57 | -24.48 | -38.46 | -15.49 | -25.17 | Upgrade |
EBT Excluding Unusual Items | 215.86 | 370.11 | 780.65 | 3,388 | 1,956 | 1,766 | Upgrade |
Impairment of Goodwill | -377.97 | -377.97 | - | -589.64 | - | -445.74 | Upgrade |
Gain (Loss) on Sale of Investments | -12.57 | -28.72 | -18.32 | -56.24 | -187.72 | -31.45 | Upgrade |
Gain (Loss) on Sale of Assets | -4.43 | -1.48 | -3.57 | -11.18 | 6.35 | -0.08 | Upgrade |
Asset Writedown | -9.65 | -13.14 | -25.72 | -242.16 | -21.53 | -2.12 | Upgrade |
Legal Settlements | - | - | - | - | -7.59 | - | Upgrade |
Other Unusual Items | 1.29 | -0.63 | 65.29 | 54.74 | 45.1 | 31.18 | Upgrade |
Pretax Income | -187.47 | -51.83 | 798.33 | 2,544 | 1,791 | 1,317 | Upgrade |
Income Tax Expense | 72.2 | 117.41 | 216.74 | 681.09 | 307.4 | 247.46 | Upgrade |
Earnings From Continuing Operations | -259.66 | -169.23 | 581.59 | 1,862 | 1,484 | 1,070 | Upgrade |
Minority Interest in Earnings | -159.08 | -188.04 | -274.13 | -428.28 | -320.72 | -267 | Upgrade |
Net Income | -418.75 | -357.28 | 307.46 | 1,434 | 1,163 | 802.93 | Upgrade |
Net Income to Common | -418.75 | -357.28 | 307.46 | 1,434 | 1,163 | 802.93 | Upgrade |
Net Income Growth | - | - | -78.56% | 23.33% | 44.83% | 131.20% | Upgrade |
Shares Outstanding (Basic) | 612 | 617 | 625 | 623 | 620 | 620 | Upgrade |
Shares Outstanding (Diluted) | 612 | 617 | 625 | 624 | 624 | 622 | Upgrade |
Shares Change (YoY) | -1.78% | -1.30% | 0.18% | -0.02% | 0.43% | 0.22% | Upgrade |
EPS (Basic) | -0.68 | -0.58 | 0.49 | 2.30 | 1.87 | 1.29 | Upgrade |
EPS (Diluted) | -0.68 | -0.58 | 0.49 | 2.30 | 1.86 | 1.29 | Upgrade |
EPS Growth | - | - | -78.60% | 23.36% | 44.21% | 130.70% | Upgrade |
Free Cash Flow | 1,373 | 844.2 | 1,220 | 691.64 | 728.42 | 1,072 | Upgrade |
Free Cash Flow Per Share | 2.24 | 1.37 | 1.95 | 1.11 | 1.17 | 1.72 | Upgrade |
Dividend Per Share | 0.250 | 0.900 | 0.060 | 0.200 | 0.135 | 0.130 | Upgrade |
Dividend Growth | -64.79% | 1400.00% | -70.00% | 48.15% | 3.85% | 1.56% | Upgrade |
Gross Margin | 27.70% | 27.75% | 30.97% | 36.85% | 38.09% | 38.06% | Upgrade |
Operating Margin | 3.10% | 4.48% | 7.56% | 18.03% | 16.26% | 17.86% | Upgrade |
Profit Margin | -3.84% | -2.93% | 2.29% | 7.07% | 8.89% | 7.54% | Upgrade |
Free Cash Flow Margin | 12.58% | 6.92% | 9.10% | 3.41% | 5.57% | 10.06% | Upgrade |
EBITDA | 709.25 | 928.27 | 1,467 | 4,247 | 2,468 | 2,195 | Upgrade |
EBITDA Margin | 6.50% | 7.61% | 10.94% | 20.94% | 18.87% | 20.61% | Upgrade |
D&A For EBITDA | 371.2 | 381.92 | 453.51 | 590.21 | 341.57 | 292.91 | Upgrade |
EBIT | 338.06 | 546.34 | 1,013 | 3,657 | 2,127 | 1,902 | Upgrade |
EBIT Margin | 3.10% | 4.48% | 7.56% | 18.03% | 16.26% | 17.86% | Upgrade |
Effective Tax Rate | - | - | 27.15% | 26.78% | 17.16% | 18.78% | Upgrade |
Revenue as Reported | 10,915 | 12,196 | 13,408 | 20,282 | 13,083 | 10,649 | Upgrade |
Advertising Expenses | - | 59.27 | 68.34 | 76.59 | 59.74 | 61.42 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.